| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |